273 related articles for article (PubMed ID: 20211191)
1. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
[TBL] [Abstract][Full Text] [Related]
2. Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.
Li Z; Liang Y; Boules M; Gordillo A; Richelson E
Neuropharmacology; 2010 Jun; 58(7):1174-8. PubMed ID: 20193696
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine receptor plasticity in neurotensin deficient mice.
Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
[TBL] [Abstract][Full Text] [Related]
4. Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.
Oliveros A; Heckman MG; Del Pilar Corena-McLeod M; Williams K; Boules M; Richelson E
J Exp Biol; 2010 Dec; 213(Pt 24):4232-9. PubMed ID: 21113004
[TBL] [Abstract][Full Text] [Related]
5. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
Smith KE; Boules M; Williams K; Richelson E
Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
[TBL] [Abstract][Full Text] [Related]
6. Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.
Li Z; Boules M; Williams K; Gordillo A; Li S; Richelson E
Neurobiol Dis; 2010 Nov; 40(2):467-77. PubMed ID: 20659557
[TBL] [Abstract][Full Text] [Related]
7. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
[TBL] [Abstract][Full Text] [Related]
9. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.
Ghisi V; Ramsey AJ; Masri B; Gainetdinov RR; Caron MG; Salahpour A
Cell Signal; 2009 Jan; 21(1):87-94. PubMed ID: 18929645
[TBL] [Abstract][Full Text] [Related]
10. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice.
Huotari M; García-Horsman JA; Karayiorgou M; Gogos JA; Männistö PT
Psychopharmacology (Berl); 2004 Feb; 172(1):1-10. PubMed ID: 14574438
[TBL] [Abstract][Full Text] [Related]
11. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
[TBL] [Abstract][Full Text] [Related]
12. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
[TBL] [Abstract][Full Text] [Related]
13. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
Prus AJ; Schuck CJ; Rusch KR; Carey LM
Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
[TBL] [Abstract][Full Text] [Related]
14. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1.
Espinoza S; Ghisi V; Emanuele M; Leo D; Sukhanov I; Sotnikova TD; Chieregatti E; Gainetdinov RR
Neuropharmacology; 2015 Jun; 93():308-13. PubMed ID: 25721394
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic abnormalities in Hdac6-deficient mice.
Fukada M; Nakayama A; Mamiya T; Yao TP; Kawaguchi Y
Neuropharmacology; 2016 Nov; 110(Pt A):470-479. PubMed ID: 27544826
[TBL] [Abstract][Full Text] [Related]
16. NQO1 regulates pharmaco-behavioral effects of d-amphetamine in striatal dopaminergic system in mice.
Go J; Ryu YK; Park HY; Choi DH; Choi YK; Hwang DY; Lee CH; Kim KS
Neuropharmacology; 2020 Jun; 170():108039. PubMed ID: 32165217
[TBL] [Abstract][Full Text] [Related]
17. Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.
Lee MR; Hinton DJ; Unal SS; Richelson E; Choi DS
Alcohol Clin Exp Res; 2011 Jan; 35(1):99-107. PubMed ID: 21039631
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
[TBL] [Abstract][Full Text] [Related]
20. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
